BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bettinger D, Schultheiss M, Boettler T, Muljono M, Thimme R, Rössle M. Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). Aliment Pharmacol Ther 2016;44:1051-61. [DOI: 10.1111/apt.13809] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Rajoriya N, Tripathi D. Editorial: complications of TIPSS - consolidation of a decade of experience. Aliment Pharmacol Ther 2017;45:179-80. [PMID: 27910144 DOI: 10.1111/apt.13843] [Reference Citation Analysis]
2 Mollaiyan A, Bettinger D, Rössle M. The underdilation of nitinol stents at TIPS implantation: Solution or illusion? European Journal of Radiology 2017;89:123-8. [DOI: 10.1016/j.ejrad.2017.01.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
3 Globig AM, Heeg M, Larsen CS, Ferreira RD, Kindle G, Goldacker S, Strohmeier V, Silva SL, Cunningham-Rundles C, Quinti I, Thimme R, Bettinger D, Schultheiß M, Warnatz K. International multicenter experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency. J Allergy Clin Immunol Pract 2021;9:2931-2935.e1. [PMID: 33722695 DOI: 10.1016/j.jaip.2021.02.056] [Reference Citation Analysis]
4 Rashidi-Alavijeh J, Kahraman A, Gerken G, Theysohn JM, Willuweit K, Hoyer DP, Lange CM, Buechter M. Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation. Sci Rep 2021;11:13834. [PMID: 34226640 DOI: 10.1038/s41598-021-93392-5] [Reference Citation Analysis]
5 Ferrarese A, Passigato N, Cusumano C, Gemini S, Tonon A, Dajti E, Marasco G, Ravaioli F, Colecchia A. Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice. World J Hepatol 2021; 13(8): 840-852 [PMID: 34552691 DOI: 10.4254/wjh.v13.i8.840] [Reference Citation Analysis]
6 Song T, Rössle M, He F, Liu F, Guo X, Qi X. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis. Dig Liver Dis 2018;50:323-30. [PMID: 29422242 DOI: 10.1016/j.dld.2018.01.123] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
7 Armstrong MJ, Gohar F, Dhaliwal A, Nightingale P, Baker G, Greaves D, Mangat K, Zia Z, Karkhanis S, Olliff S, Mehrzad H, Steeds RP, Tripathi D. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis. Aliment Pharmacol Ther 2019;49:797-806. [DOI: 10.1111/apt.15164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Cannataci C, Cimo' B, Mamone G, Tuzzolino F, D'Amico M, Cortis K, Maruzzelli L, Miraglia R. Portal vein puncture-related complications during transjugular intrahepatic portosystemic shunt creation: Colapinto needle set vs Rösch-Uchida needle set. Radiol Med 2021;126:1487-95. [PMID: 34405340 DOI: 10.1007/s11547-021-01404-1] [Reference Citation Analysis]
9 Buechter M, Manka P, Gerken G, Canbay A, Blomeyer S, Wetter A, Altenbernd J, Kahraman A, Theysohn JM. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience. Dig Dis 2018;36:218-27. [PMID: 29316565 DOI: 10.1159/000486030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Griffin AS, Preece SR, Ronald J, Smith TP, Suhocki PV, Kim CY. Hemorrhage risk with transjugular intrahepatic portosystemic shunt (TIPS) insertion at the main portal vein bifurcation with stent grafts. Diagn Interv Imaging 2017;98:837-42. [PMID: 28843589 DOI: 10.1016/j.diii.2017.07.006] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Sturm L, Praktiknjo M, Bettinger D, Huber JP, Volkwein L, Schmidt A, Kaeser R, Chang J, Jansen C, Meyer C, Thomas D, Thimme R, Trebicka J, Schultheiß M. Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt. Hepatol Commun 2021;5:650-60. [PMID: 33860123 DOI: 10.1002/hep4.1654] [Reference Citation Analysis]
12 Sturm L, Bettinger D, Giesler M, Boettler T, Schmidt A, Buettner N, Thimme R, Schultheiss M. Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS). United European Gastroenterol J 2018;6:1380-90. [PMID: 30386611 DOI: 10.1177/2050640618795928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
13 Zuo L, Lv Y, Wang Q, Yin Z, Wang Z, He C, Guo W, Niu J, Bai W, Li K, Yu T, Yuan X, Chen H, Liu H, Xia D, Wang E, Luo B, Li X, Yuan J, Han N, Nie Y, Fan D, Han G. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation. J Vasc Interv Radiol. 2019;30:148-153.e2. [PMID: 30638778 DOI: 10.1016/j.jvir.2018.08.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Schultheiß M, Bettinger D, Thimme R, Rössle M. 30 Jahre transjugulärer intrahepatischer portosystemischer Shunt (TIPS) – Rückblick und Perspektive. Z Gastroenterol 2020;58:877-89. [DOI: 10.1055/a-1217-7866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 David A, Liberge R, Meyer J, Morla O, Leaute F, Archambeaud I, Gournay J, Trewick D, Frampas E, Perret C, Douane F. Ultrasonographic guidance for portal vein access during transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagnostic and Interventional Imaging 2019;100:445-53. [DOI: 10.1016/j.diii.2019.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhuang Z, Ma J, Ju S, Gu G, Zhang W, Yang M, Zhang Z, Ma L, Yan Z, Luo J. A new alternative technique for the guidance of transjugular intrahepatic portosystemic shunt creation using DSA overlay reference. Acta Radiol 2022;:2841851221086963. [PMID: 35313745 DOI: 10.1177/02841851221086963] [Reference Citation Analysis]
17 Liu J, Ma J, Zhou C, Yang C, Huang S, Shi Q, Xiong B. Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation. Clin Transl Gastroenterol 2021;12:e00376. [PMID: 34140457 DOI: 10.14309/ctg.0000000000000376] [Reference Citation Analysis]
18 Gairing SJ, Müller L, Kloeckner R, Galle PR, Labenz C. Review article: post-TIPSS hepatic encephalopathy-current knowledge and future perspectives. Aliment Pharmacol Ther 2022. [PMID: 35181894 DOI: 10.1111/apt.16825] [Reference Citation Analysis]
19 Rodrigues SG, Sixt S, Abraldes JG, De Gottardi A, Klinger C, Bosch J, Baumgartner I, Berzigotti A. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther. 2019;49:20-30. [PMID: 30450634 DOI: 10.1111/apt.15044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
20 Luo X, Wang X, Yu J, Zhu Y, Xi X, Ma H, Yang L. Transjugular intrahepatic portosystemic shunt creation: three-dimensional roadmap versus CO2 wedged hepatic venography. Eur Radiol 2018;28:3215-20. [PMID: 29460071 DOI: 10.1007/s00330-018-5316-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tseng Y, Ma L, Lv M, Luo T, Liu C, Wei Y, Liu C, Zhou J, Yan Z, Xu P, Hu G, Ding H, Ji Y, Chen S, Wang J. The role of a multidisciplinary team in the management of portal hypertension. BMC Gastroenterol 2020;20:83. [PMID: 32245413 DOI: 10.1186/s12876-020-01203-4] [Reference Citation Analysis]
22 Tseng Y, Ma L, Lv M, Luo T, Liu C, Wei Y, Liu C, Zhou J, Yan Z, Xu P, Hu G, Ding H, Ji Y, Chen S, Wang J. The role of a multidisciplinary team in the management of portal hypertension. BMC Gastroenterol 2020;20:83. [PMID: 32245413 DOI: 10.1186/s12876-020-01203-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Bucher JN, Hollenbach M, Strocka S, Gaebelein G, Moche M, Kaiser T, Bartels M, Hoffmeister A. Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt. World J Gastroenterol 2019; 25(43): 6430-6439 [PMID: 31798279 DOI: 10.3748/wjg.v25.i43.6430] [Reference Citation Analysis]
24 Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol 2021;74:1362-72. [PMID: 33508376 DOI: 10.1016/j.jhep.2021.01.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
25 Oey RC, de Wit K, Moelker A, Atalik T, van Delden OM, Maleux G, Erler NS, Takkenberg RB, de Man RA, Nevens F, van Buuren HR. Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study. Aliment Pharmacol Ther 2018;48:975-83. [PMID: 30136292 DOI: 10.1111/apt.14947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]